Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 21, 2017
Patent Application Number
14051244
Date Filed
October 10, 2013
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Methods and compositions for modifying T-cells in which PD1 and/or CTLA-4 is repressed and/or inactivated using fusion proteins such as artificial transcription factors and nucleases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
